What is the ticker symbol for Genocea Biosciences?

Genocea Biosciences trades under the ticker GNCA on NASDAQ.

What sector does Genocea Biosciences operate in?

Genocea Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GNCA in a portfolio?

PortView shows GNCA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Genocea Biosciences (GNCA) Stock Analysis

NASDAQHealthcareBiotechnology

$0.00-85.71%

1-year price historyRange $0.00 – $1.38

52-week range$0.00

$0.00$1.45

What Genocea Biosciences does

Genocea Biosciences, Inc. is a biopharmaceutical company focused on pioneering novel cancer immunotherapies. It leverages its distinctive ATLAS discovery platform to meticulously profile each patient's CD4+ and CD8+ T cell immune responses against specific targets or antigens, which are identified through next-generation sequencing of their individual tumors. Among its lead clinical-stage candidates is GEN-011, an adoptive T cell therapy currently in Phase 1/2a trials for solid tumors. Also undergoing Phase 1/2a clinical evaluation is GEN-009, an investigational neoantigen vaccine designed to deliver adjuvanted synthetic long peptides corresponding to anti-tumor neoantigens pinpointed by ATLAS. Established in 2006 and based in Cambridge, Massachusetts, the company notably filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts on July 5, 2022.

Key metrics

Market cap

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.02

50-day avg

$0.00

200-day avg

$0.11

52-week high

$1.45

52-week low

$0.00

CEO

William Clark

ETFs linked to GNCA

Broad-market and Healthcare sector ETFs an investor holding Genocea Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GNCA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GNCA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Genocea Biosciences?: Genocea Biosciences trades under the ticker GNCA on NASDAQ.
Which exchange is GNCA listed on?: GNCA is listed on NASDAQ.
What sector does Genocea Biosciences operate in?: Genocea Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GNCA in a portfolio?: PortView shows GNCA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.